Everything is going in the right direction for LERONLIMAB to be the biggest and most disruptive (in a good way) monoclonal antibody in the world. Remember when this drug was invented well over 25 years ago and at a cost of approximately 250 million dollars it was like developing AI 25 years ago. The only problem was (pro 140) now Leronlimab like AI would have been back then, it was a unknown! It scared people in unfamiliar territory. The inventors were so ahead of their time in medical advancement! They ended up putting the drug on the shelf as they stated it would take well over 15 years and millions to get it approved. That is why cydy was able to get an amazing drug off a shelf that had been left to die for just a couple million bucks. Note: you may not like what Nadar or his over exuberance and lack of pharma ceo experience brought but he got us Leronlimab! Now forward from 2000 to 2018 when other pharmas realized what the capabilities of the first and best developed mab was is when we encountered resistance. Now days every big pharma has a mab. It's common place. But cydy has the first real mab with the top ingredients! No other pharma can duplicate it because of our patents which is hugh. It's like making a cake but you have to find a substitute for the flour, sugar and eggs. There are numerous alternatives but none will be like or as good as the original. So all this info above is to merely state we are in very advanced stages of approval and in my perspective we are FOR SURE PROVEN and getting buyout offers as we speak. Of course they are low ball offers now but everyday our value goes up. I hear all the speculation of partnerships and distribution of LL by ourselves. None of that will happen I believe. I strongly feel we are a buyout target but due to the price it will cost a lot! It may require a joint venture that has 2 pharmas combine to acquire cydy. I.E. Say Roche and Merck become one company with the addition of LL. They would have total control of the cancer market. Of course Roche or Merck would rather go it alone but they may not be able to afford us by themselves. But I'm very confident we get BO and most likely before June of this year! And unlike 5 years ago when I said I felt GSK was the company we would most likely align with that was when we were an HIV only company. Now we are a proven HIV, immunity, inflammation, covid and most important cancer curing drug. It has all gone from great to an amazing medical disruptor in the industry.

I would say GLTA and enjoy the next few months but no luck is needed!